COMMUNIQUÉS West-GlobeNewswire

Cybrexa Therapeutics Closes $13.4M in Series B1 Funding Round
20/06/2019
NEW HAVEN, Conn., June 20, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced the [...]
Predictive Technology Group Announces the Presentation of New Genetic Findings in Endometriosis at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology
20/06/2019
SALT LAKE CITY, June 20, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned subsidiary of Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease [...]
BeyondSpring Set to Join FTSE Russell 3000® Index
20/06/2019
NEW YORK, June 20, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, announced today that it will join the FTSE Russell 3000 [...]
Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
20/06/2019
YARDLEY, Pa., June 20, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive [...]
BioDelivery Sciences Named to the Russell 3000® Index
20/06/2019
Recognition is a Result of Company’s Performance over the Last 12 Months RALEIGH, N.C., June 20, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is set to be added to the broad-market [...]
Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis
20/06/2019
CAMBRIDGE, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
OPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® Test
20/06/2019
MIAMI, June 20, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that the Company has submitted a de novo request to the U.S. Food and Drug Administration (FDA) seeking regulatory clearance for the [...]
Albireo Announces Launch of “PFIC Voices”
20/06/2019
New Initiative to Create Awareness and Understanding of Life-Threatening Pediatric Liver Disease Announced new PFIC Voices website, www.PFICvoices.com BOSTON, June 20, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. ( [...]
VBI Vaccines to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
20/06/2019
CAMBRIDGE, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Alimera’s ILUVIEN® Receives Positive NICE Recommendation for Non-Infectious Posterior Uveitis
20/06/2019
NICE decision is key milestone expanding access to patients in the United Kingdom ATLANTA, June 20, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and [...]
BioSig Technologies Issues June 2019 Shareholder Letter
20/06/2019
Top Tier New Corporate Talent and First Successful Clinical Results from Leading Medical Institutions Pave Way for Commercial Rollout Santa Monica, CA, June 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ [...]
BeiGene Presents Pivotal Phase 2 Clinical Results of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma at the 15th International Conference on Malignant Lymphoma (ICML)
20/06/2019
Company to Host Investor Conference Call and Webcast of Mid-2019 Clinical Data Updates Today, Thursday, June 20 at 8:00 a.m. EDT CAMBRIDGE, Mass. and BEIJING, China, June 20, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. ( [...]
Arbutus receives regulatory clearance to initiate Phase 1a/1b Clinical Trial of AB-729
20/06/2019
- AB-729 is a subcutaneously-administered RNAi agent targeting HBV replication and HBsAg antigen production - Supports corporate objective to combine AB-729 with AB-506, Arbutus’ proprietary oral capsid inhibitor [...]
T2 Biosystems Introduces New Clinical Data and Updates Regarding Expanding Capabilities of its Rapid Diagnostic Technology at ASM Microbe 2019
20/06/2019
Real-world data to highlight substantial impact T2Bacteria® has made on patient outcomes LEXINGTON, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of [...]
Radient Technologies Inc. Provides Update on Progress of Cannabis and Hemp Extraction Facilities and Issues Shares for Services
20/06/2019
EDMONTON, Alberta, June 20, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce it has awarded the mandate for the second phase of [...]
Theratechnologies Launches Direct-to-Consumer Campaigns for TROGARZO® and EGRIFTA® in the United States
20/06/2019
MONTREAL, June 20, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce the launch of two direct-to-consumer campaigns for TROGARZO ® (ibalizumab-uiyk) for injection and [...]
Theratechnologies lance deux campagnes publicitaires aux États-Unis axées vers les usagers potentiels de TROGARZO(MD) et d’EGRIFTA(MD)
20/06/2019
MONTRÉAL, 20 juin 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer le lancement de deux campagnes publicitaires axées vers les usagers potentiels de TROGARZO MD ( [...]
Axovant and Yposkesi Sign Strategic Gene Therapy Development and Manufacturing Partnership
20/06/2019
Partnership secures access to reserved cGMP capacity and resources at Yposkesi for manufacturing to support the global development and commercialization of Axovant’s gene therapy programs BASEL, Switzerland and CORBEIL- [...]
Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019
20/06/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019 Oxford, UK, and Cambridge, MA, US, 20 June 2019 – Summit Therapeutics [...]

Pages